# Eton Pharmaceuticals, Inc.: Form 8-K, filed May 14, 2026

- Company: [Eton Pharmaceuticals, Inc.](/companies/eton.md) (CIK 1710340)
- Form: 8-K
- Filed: 2026-05-14
- Accepted by EDGAR: May 14, 2026, 16:16 ET
- Period: 2026-05-14
- Accession: 0001437749-26-017063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1710340/000143774926017063/eton20260322_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1710340/000143774926017063/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1710340/000143774926017063/eton20260322_8k.htm

Filed May 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-017063. Last ingested by Listed: Nov 5, 2026, 19:03 ET. No prices; not investment advice.